Cellino, a leader in advanced biomanufacturing, today announced that its optical biomanufacturing technology for generating induced pluripotent stem cells (iPSCs) has received the FDA’s Advanced ...
Launched in 2024, IRO is one of the first technologies to receive AMT designation, validating the platform as a leading, next-generation solution for overcoming the critical challenges in cell and ...
Ori Biotech has lassoed a significant milestone for its space- and cost-efficient cell and gene therapy manufacturing platform. The FDA has granted the company’s IRO platform an Advanced Manufacturing ...
NanoMosaic's technology is designed to support upstream and downstream process development, quality control, and release testing.
Pharmaceutical Technology on MSN
FDA’s new scheme to boost US manufacturing commences despite uncertainty
The PreCheck programme, first unveiled in June 2025, aims to speed up drug facility construction.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results